Faro’s $37.3M Series B: Agentic AI for Clinical Development
Faro AI raised $37.3M Series B co-led by Merck Global Health Innovation Fund and S32, with General Catalyst returning. Platform used by 6 of the world’s 10 largest pharma companies. Structured clinical-intent data — not chat-on-PDFs.